Idiopathic pulmonary fibrosis (IPF) is a life-limiting interstitial lung disease. We are unsure what causes it, there is no cure and patients experience debilitating symptoms and long delays before diagnosis is confirmed. Of the 32,500 people with the disease, 300 people die each year and the quality of palliative and end of life care for these patients varies considerably.
Primary Health Care. 28, 4, 5-5. doi: 10.7748/phc.28.4.5.s1
or
Alternatively, you can purchase access to this article for the next seven days. Buy now
Are you a student? Our student subscription has content especially for you.
Find out more
